255 related articles for article (PubMed ID: 36131875)
1. Recent advances in phase change material based nanoplatforms for cancer therapy.
Cao C; Yang N; Dai H; Huang H; Song X; Zhang Q; Dong X
Nanoscale Adv; 2021 Jan; 3(1):106-122. PubMed ID: 36131875
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatforms: The future of oral cancer treatment.
Senevirathna K; Jayawickrama SM; Jayasinghe YA; Prabani KIP; Akshala K; Pradeep RGGR; Damayanthi HDWT; Hettiarachchi K; Dorji T; Lucero-Prisno DE; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
Health Sci Rep; 2023 Aug; 6(8):e1471. PubMed ID: 37547360
[TBL] [Abstract][Full Text] [Related]
4. Precisely NIR-II-activated and pH-responsive cascade catalytic nanoreactor for controlled drug release and self-enhanced synergetic therapy.
Hu P; Zhao S; Shi J; Li F; Wang S; Gan Y; Liu L; Yu S
Nanoscale; 2022 Sep; 14(34):12219-12231. PubMed ID: 35582977
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.
Chang D; Ma Y; Xu X; Xie J; Ju S
Front Bioeng Biotechnol; 2021; 9():707319. PubMed ID: 34249894
[TBL] [Abstract][Full Text] [Related]
6. ROS-Activated nanoscale coordination polymers for enhanced ultrasound-mediated therapy for the treatment of cancer.
Zhao J; Shi J; Meng X; Gong C; Wu P; Yang Z; Dong H
Acta Biomater; 2022 Apr; 143():372-380. PubMed ID: 35219868
[TBL] [Abstract][Full Text] [Related]
7. Applications of phase change materials in smart drug delivery for cancer treatment.
Bao J; Tu H; Li J; Li Y; Yu S; Gao J; Lei K; Zhang F; Li J
Front Bioeng Biotechnol; 2022; 10():991005. PubMed ID: 36172021
[TBL] [Abstract][Full Text] [Related]
8. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional phase-change hollow mesoporous Prussian blue nanoparticles as a NIR light responsive drug co-delivery system to overcome cancer therapeutic resistance.
Chen H; Ma Y; Wang X; Zha Z
J Mater Chem B; 2017 Sep; 5(34):7051-7058. PubMed ID: 32263896
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer.
Majerník M; Jendželovský R; Vargová J; Jendželovská Z; Fedoročko P
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631660
[TBL] [Abstract][Full Text] [Related]
12. Phase-Change Materials for Controlled Release and Related Applications.
Qiu J; Huo D; Xia Y
Adv Mater; 2020 Jun; 32(25):e2000660. PubMed ID: 32383215
[TBL] [Abstract][Full Text] [Related]
13. Smart Nanoparticles for Chemo-Based Combinational Therapy.
Shrestha B; Wang L; Brey EM; Uribe GR; Tang L
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34201333
[TBL] [Abstract][Full Text] [Related]
14. Multisynergistic Platform for Tumor Therapy by Mild Microwave Irradiation-Activated Chemotherapy and Enhanced Ablation.
Long D; Liu T; Tan L; Shi H; Liang P; Tang S; Wu Q; Yu J; Dou J; Meng X
ACS Nano; 2016 Oct; 10(10):9516-9528. PubMed ID: 27689440
[TBL] [Abstract][Full Text] [Related]
15. Stimuli-Responsive Nanoplatform-Assisted Photodynamic Therapy Against Bacterial Infections.
Zhou Y; Deng W; Mo M; Luo D; Liu H; Jiang Y; Chen W; Xu C
Front Med (Lausanne); 2021; 8():729300. PubMed ID: 34604266
[TBL] [Abstract][Full Text] [Related]
16. Endogenous stimuli-responsive drug delivery nanoplatforms for kidney disease therapy.
Fang H; Xu S; Wang Y; Yang H; Su D
Colloids Surf B Biointerfaces; 2023 Dec; 232():113598. PubMed ID: 37866237
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers.
Ban Q; Bai T; Duan X; Kong J
Biomater Sci; 2017 Jan; 5(2):190-210. PubMed ID: 27990534
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.
Wu K; Yu B; Li D; Tian Y; Liu Y; Jiang J
Front Oncol; 2022; 12():805978. PubMed ID: 35242707
[TBL] [Abstract][Full Text] [Related]
19. Strategies and applications of covalent organic frameworks as promising nanoplatforms in cancer therapy.
Valenzuela C; Chen C; Sun M; Ye Z; Zhang J
J Mater Chem B; 2021 Apr; 9(16):3450-3483. PubMed ID: 33909746
[TBL] [Abstract][Full Text] [Related]
20. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
Sun Y; Davis E
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
